|1|Management of psoriasis in patients treated with anti-TNF-I+ therapy for inflammatory bowel disease. (23972498)
Biswas S.... De Silva A.
|2|Factors associated with thiopurine non-adherence in patients with inflammatory bowel disease. (24099471)
Goodhand J.R.... Lindsay J.O.
|3|Acute segmentary ulcerative duodenitis induced by Streptococcus pyogenes mimicking inflammatory bowel disease. (23994254)
Carrascosa M.F.... GA^mez-RomA!n J.
|4|Survival after inflammatory bowel disease-associated colorectal cancer in the Colon Cancer Family Registry. (23745025)
Adams S.V.... Newcomb P.A.
|5|Exploring the role of the inflammatory bowel disease nurse specialist. (24037398)
Greveson K.... Woodward S.
|6|Large serrated polyp with KRAS mutation in inflammatory bowel disease: a "nondysplastic dysplasia-associated lesion or mass (DALM)"? (23945926)
Setaffy L.... Langner C.
|7|Effects of haptoglobin polymorphisms and deficiency on susceptibility to inflammatory bowel disease and on severity of murine colitis. (21708824)
MA!rquez L.... Vermeire S.
|8|Association between Cogan's syndrome and inflammatory bowel disease: a case series. (21272808)
Scharl M.... Vavricka S.R.
|9|Endogenous interleukin-10 constrains Th17 cells in patients with inflammatory bowel disease. (22176654)
Wilke C.M.... Zou W.
|10|Novel immunomodulatory properties of cirsilineol through selective inhibition of IFN-gamma signaling in a murine model of inflammatory bowel disease. (19698701)
Sun Y.... Xu Q.
|11|Transcutaneous posterior tibial nerve stimulation for fecal incontinence in inflammatory bowel disease patients: a therapeutic option? (18972550)
Vitton V.... Mion F.
|12|Interleukin-10 in inflammatory bowel disease. (19890110)
|13|Immunomodulatory effects of 1,25-dihydroxyvitamin D3 on TH1/TH2 cytokines in inflammatory bowel disease: an in vitro study. (19309553)
Ardizzone S.... Bianchi Porro G.
|14|Bile synthesis in rat models of inflammatory bowel diseases. (17359490)
Dikopoulos N.... Weidenbach H.
|15|Stimulating erythropoiesis in inflammatory bowel disease associated anemia. (17828809)
Tsiolakidou G.... Koutroubakis I.E.
|16|Phosphodiesterase 4 inhibitors and inflammatory bowel disease: emerging therapies in inflammatory bowel disease. (17714033)
Keshavarzian A.... Banan A.
|17|IL23R Arg381Gln is associated with childhood onset inflammatory bowel disease in Scotland. (17337463)
Van Limbergen J.... Satsangi J.
|18|5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease. (17889397)
Pertuit D.... Lamprecht A.
|19|Genetic advances in inflammatory bowel disease. (16901383)
|20|Loss of fragile histidine triad protein expression in inflammatory bowel disease. (17143956)
Xu C.M.... Qiao C.H.
|21|Role of the IBD5 susceptibility locus in the inflammatory bowel diseases. (16534425)
Reinhard C.... Rioux J.D.
|22|Ubiquitin protein modification and signal transduction: implications for inflammatory bowel diseases. (16306773)
Taylor C.... Jobin C.
|23|Severe chronic active Epstein-Barr virus infection mimicking steroid-dependent inflammatory bowel disease. (15750464)
Roth D.E.... Robinson J.
|24|Association of Fas-670 gene polymorphism with inflammatory bowel disease in Chinese patients. (15637757)
Xia B.... Li J.
|25|The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease. (15842590)
Cantor M.J.... Bernstein C.N.
|26|Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases. I. Immunology and therapeutic potential of antiadhesion molecule therapy in inflammatory bowel disease. (15647604)
van Assche G.... Rutgeerts P.
|27|Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells. (15932502)
Matsumoto S.... Sata M.
|28|Review article: bone disease in inflammatory bowel disease. (15352893)
|29|Key role of mast cells and their major secretory products in inflammatory bowel disease. (14760748)
|30|Keratin 8 Y54H and G62C mutations are not associated with inflammatory bowel disease. (15248378)
BA1ning C.... Witt H.
|31|Hyperexpression of inducible costimulator and its contribution on lamina propria T cells in inflammatory bowel disease. (14988837)
Sato T.... Hibi T.
|32|Colonic expression of MUC2, MUC5AC, and TFF1 in inflammatory bowel disease in children. (15097436)
Shaoul R.... Marcon M.A.
|33|Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms. (15223609)
Balding J.... Smith O.P.
|34|Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease. (14568967)
Bamias G.... Cominelli F.
|35|Thiopurine S-methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel disease. (12940924)
Gearry R.B.... Kennedy M.A.
|36|Platelets and anticoagulant capacity in patients with inflammatory bowel disease. (12214155)
Larsen T.B.... Hey H.
|37|Integrating anti-tumor necrosis factor therapy in inflammatory bowel disease: current and future perspectives. (11467623)
Blam M.E.... Lichtenstein G.R.
|38|Post-genome challenges against inflammatory bowel diseases]. (11197852)
Takei Y.... Nagasako K.
|39|In vivo effects of recombinant human interleukin-10 on lymphocyte phenotypes and leukocyte activation markers in inflammatory bowel disease. (11094868)
Dejaco C.... Gasche C.
|40|Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease. (10792371)
Louis E.... Malaise M.
|41|Circulating levels of glucagon-like peptide-2 in human subjects with inflammatory bowel disease. (10749795)
Xiao Q.... Brubaker P.L.
|42|Antioxidant effects of aminosalicylates and potential new drugs for inflammatory bowel disease: assessment in cell-free systems and inflamed human colorectal biopsies. (10102970)
Simmonds N.J.... Rampton D.S.
|43|Genetic analysis in Italian families with inflammatory bowel disease supports linkage to the IBD1 locus--a GISC study. (10439963)
Annese V.... Andriulli A.
|44|Growth factors in inflammatory bowel disease. (10028449)
Beck P.L.... Podolsky D.K.
|45|Current concept of the role of monocytes/macrophages in inflammatory bowel disease--balance of proinflammatory and immunosuppressive mediators. (9759608)
LA1gering N.... Domschke W.
|46|Interleukin 15 activity in the rectal mucosa of inflammatory bowel disease. (9609761)
Sakai T.... Yoshikai Y.
|47|Visualising E-selectin in the detection and evaluation of inflammatory bowel disease. (9771404)
Bhatti M.... Hodgson H.J.
|48|Hemostatic abnormalities in inflammatory bowel disease. (9163067)
Chiarantini E.... Abbate R.
|49|Antibodies to intercellular adhesion molecule-1 ameliorate the inflammatory response in acetic acid-induced inflammatory bowel disease. (7616434)
Wong P.Y.... Sun F.F.
|50|Characterization of circulating interleukin-1 receptor antagonist expression in children with inflammatory bowel disease. (8082495)
Hyams J.S.... Kreutzer D.L.